glp-1 agonists brand names are commonly used medications to treat Type 2 Diabetes. They are subcutaneous injections, so many patients mistaken these medications for insulin. However, GLP-1's are very different. They work primarily on Targeting GLP-1, GIP & GCG

Evidence is emerging that glucagon-like peptide-1 (GLP-1) receptor agonists have anti-inflammatory and chondroprotective properties independent of their effects on weight loss

While newly approved pharmacotherapies such as glucagon-like peptide-1 receptor agonists (GLP-1 RAs) show efficacy, their clinical utility remains constrained by dose-dependent gastrointestinal complications, underscoring the urgent need for safer alternatives

In clinical trials, people using GLP-1 drugs lost an average of about 10 pounds more than people using a placebo

Are YOU safe?

It has been studied in human clinical trials and shown to support metabolic balance, healthy blood glucose regulation, inflammation management, and improved insulin function

A comprehensive program of nutritional and lifestyle counseling is critical to maximize overall efficacy and improve cost-effectiveness of GLP-1s for obesity.